About the Testicular Volume Calculator
This calculator estimates testicular volume using the prolate ellipsoid formula: Volume = Length × Width × Height × 0.523. This method is used in scrotal ultrasound and is the gold standard for volume estimation in clinical and research settings. The formula applies the mathematical constant π/6 (approximately 0.5236) as a correction factor to convert the product of three orthogonal diameters into an estimated volume in mL.
The testis is an ovoid organ composed primarily of seminiferous tubules (approximately 80% of parenchymal volume) and interstitial (Leydig) cells. The seminiferous tubules contain Sertoli cells and spermatogonia responsible for spermatogenesis, while Leydig cells produce testosterone in response to LH stimulation. Testicular volume is therefore a direct proxy for both spermatogenic capacity (number of spermatogonia) and, less directly, androgen production. A reduction in testicular volume below normal thresholds indicates loss of seminiferous tubule mass and is a clinically important finding in the evaluation of male infertility and hypogonadism.
Testicular volume has important clinical applications in pediatric and adolescent medicine (pubertal staging using Tanner criteria), male reproductive endocrinology (hypogonadism evaluation), andrology and infertility (semen analysis correlation), and scrotal ultrasonography (characterizing testicular pathology). The Prader orchidometer, a set of ellipsoid beads of known volumes (1–25 mL), has been the traditional clinical tool for testicular volume estimation, but ultrasound with the ellipsoid formula provides superior accuracy and reproducibility.
How to Use This Calculator
Obtain three orthogonal testicular measurements from scrotal ultrasound. Enter the values in centimeters, then press "Calculate Volume." The result is classified against normal adult reference ranges. Measure each testis separately and record both volumes for clinical comparison.
Length — the craniocaudal (superior-inferior) dimension, measured from the superior to the inferior pole of the testis in the longitudinal plane. This is the longest testicular dimension and is the single most informative measurement for screening.
Width — the transverse (medial-lateral) diameter measured perpendicular to the length in the transverse plane.
Height (AP diameter) — the anteroposterior diameter, measured perpendicular to both length and width. On scrotal ultrasound, this is obtained in the sagittal or transverse view depending on orientation.
Measure the testicular parenchyma only — exclude the epididymis, which lies along the posterior-superior aspect of the testis and can add 1–3 mL to apparent volume if inadvertently included. The epididymis should be measured and reported separately.
Interpretation Guide
| Category | Volume Range | Clinical Significance |
|---|---|---|
| Normal adult (18+) | 15 – 25 mL | Normal spermatogenesis expected |
| Low-normal adult | 12 – 15 mL | Borderline; monitor if symptomatic |
| Atrophic | < 12 mL | Evaluate for hypogonadism, prior orchitis |
| Enlarged | > 30 mL | Consider varicocele, neoplasm, orchitis |
Normal adult testicular volume per testis is 15–25 mL when measured by ultrasound ellipsoid formula. Volumes of 12–15 mL are borderline and should be interpreted in clinical context — borderline atrophy in a man with normal semen parameters requires no intervention, whereas borderline atrophy in a man with oligospermia and elevated FSH suggests impaired spermatogenesis. Volume below 12 mL per testis is considered atrophic and warrants investigation for primary (hypergonadotropic) or secondary (hypogonadotropic) hypogonadism.
Bilateral testicular volumes should always be compared. A difference of more than 20–30% between the two testes (significant asymmetry) may reflect unilateral pathology such as prior torsion, varicocele-related atrophy, or focal intratesticular pathology. Unilateral testicular enlargement above 30 mL should prompt evaluation for testicular malignancy with tumor markers (AFP, beta-hCG, LDH) and oncology referral if indicated.
Pubertal Staging and Testicular Volume
Testicular volume is the primary indicator of pubertal onset in boys. The Tanner staging system for male puberty is anchored by testicular volume thresholds: testicular enlargement to ≥4 mL (Tanner stage 2) is the first sign of puberty, typically occurring between ages 9–14. Delayed puberty is diagnosed when Tanner stage 2 has not been reached by age 14 in boys. Serial orchidometry or ultrasound measurements are used to monitor pubertal progression and identify boys with hypogonadotropic hypogonadism (e.g., Kallmann syndrome) or constitutional delay of growth and puberty.
Clinical Applications
Testicular volume assessment is used in the evaluation of male infertility, hypogonadism, and scrotal pathology. Volume correlates with total germ cell number and is a proxy for spermatogenic capacity. A volume <12 mL suggests significant impairment of spermatogenesis. In the fertility workup, testicular volume is combined with semen analysis parameters (sperm concentration, motility, morphology), reproductive hormones (FSH, LH, testosterone, inhibin B), and genetics (karyotype, Y-chromosome microdeletion analysis) to characterize the etiology of male factor infertility.
Asymmetry and Bilateral Assessment
Bilateral volumes should be compared. Asymmetry > 20% may be significant. Unilateral atrophy may follow torsion, orchitis, or varicocele. Unilateral enlargement raises concern for neoplasm and should prompt tumor marker evaluation (AFP, beta-hCG, LDH) and oncology referral. In men with clinical or subclinical varicocele, the ipsilateral testis is often smaller than the contralateral testis due to impaired venous drainage and thermal injury to the germinal epithelium. Varicocelectomy in adolescents with ≥20% volume asymmetry is recommended by the American Urological Association (AUA) to prevent progressive ipsilateral atrophy.
Orchidometer vs. Ultrasound
The Prader orchidometer is commonly used in clinical practice but tends to overestimate volume by 10–30% compared to ultrasound, because the orchidometer beads include the epididymis and surrounding cremasteric fascia in the physical comparison. Ultrasound with the ellipsoid formula is the most accurate non-invasive method and is preferred for research and detailed clinical assessment. For clinical trials (e.g., testosterone therapy, hypogonadism treatment), ultrasound volumetry is the standard method for quantifying testicular volume change.
Limitations & Considerations
The ellipsoid formula assumes a regular oval shape. Testes with significant focal pathology (intratesticular cysts, calcifications, focal tumors) have irregular parenchymal distribution that reduces formula accuracy. Additionally, the formula measures total testicular volume including both seminiferous tubule and Leydig cell compartments, and cannot distinguish between conditions primarily affecting one compartment versus the other.
Testicular volume measured by ultrasound excludes the epididymis and thus provides a smaller value than clinical orchidometry. When comparing ultrasound volumes to published normative data obtained by orchidometer, a 10–20% adjustment may be appropriate. Always note whether published reference data were obtained by orchidometer or ultrasound when applying thresholds.
The reference range of 15–25 mL represents typical adult European and North American populations. Population-based normative data vary by ethnicity and geographic region. Some studies report slightly higher mean volumes in African populations and slightly lower in Asian populations, though overlap is substantial. For individual patients near the threshold, clinical context (symptoms, semen analysis, hormone levels) is more informative than volume alone.
References
Sakamoto H, et al. Testicular volume measurements using Prader orchidometer versus ultrasound in patients with infertility. Int J Urol. 2007;14(12):1096-1099.
World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen (6th ed). 2021.
Dohle GR, et al. Male infertility: EAU guidelines. European Association of Urology. 2022. Available at: uroweb.org.
Bojesen A, et al. Testicular volume as a predictor of hormonal and reproductive function in patients with Klinefelter syndrome. Eur J Endocrinol. 2011;165(5):777-784.